Not Losing Weight on Wegovy? Here's Why It Happens

Your dose may not have reached the level where Wegovy works for you

Wegovy's titration schedule exists for a specific physiological reason: starting at a low dose reduces the nausea and gastrointestinal upset that can otherwise make people stop treatment early. The 0.25mg and 0.5mg weekly doses are not intended to produce significant weight loss. Most people who find they're not losing any weight on Wegovy during the first eight to twelve weeks are simply still working through the titration phase. Progress on the timeline for Wegovy to produce weight loss is almost always anchored to the maintenance dose, which is 2.4mg weekly under the standard UK schedule, or up to 7.2mg with the higher-dose pen now approved by the MHRA.

The STEP 1 trial, published in the New England Journal of Medicine, reported an average of around 15% body weight reduction over 68 weeks at 2.4mg, but that average includes the entire titration period. Weight loss during the escalation months tends to be modest; the curve steepens once maintenance is sustained. If you have been on maintenance dose for twelve weeks or more and weight is genuinely static, that is a different conversation to have with your prescriber.

Worth knowing: some people tolerate dose increases more slowly than the standard four-week schedule, which is entirely appropriate, a slower escalation simply delays the point at which the medicine is fully active. That is not failure; it is the prescriber protecting your comfort.

Appetite reduction does not automatically mean a calorie deficit

One of the things our prescribers hear regularly is: "I'm eating less than I ever have, so why is the scale not moving?" Semaglutide slows gastric emptying and reduces appetite through GLP-1 receptor activity, which is documented on the NHS medicines page for semaglutide. What it cannot do is guarantee that reduced hunger translates into a meaningful energy deficit for every individual.

A few patterns tend to undermine the effect. Liquid calories (juice, alcohol, coffee drinks, protein shakes) are processed differently to solid food and do not trigger the same satiety signals; someone drinking 400–500 calories a day may feel less hungry at mealtimes yet still be in energy balance. Highly processed foods, which tend to be calorie-dense and low in volume, can similarly allow significant intake even when appetite feels suppressed. Protein adequacy is the positive counterpart: diets with adequate protein on Wegovy tend to preserve more muscle tissue and support a stronger sense of fullness. The NHS guidance on healthy weight covers dietary principles that sit alongside any medical treatment.

A food diary (even a rough one kept on your phone for two weeks) often reveals more than a lengthy conversation about willpower. The data tends to be more useful than the feeling.

Biological adaptation: when a plateau is not the same as treatment failure

Weight loss plateaus are not unique to Wegovy. They are a fundamental feature of human metabolism. As body weight falls, the body's resting energy expenditure also falls, it requires fewer calories to maintain a lower mass, and some evidence suggests metabolic adaptation goes further than mass alone explains. This is biology protecting a body it perceives as under threat, not a sign that anything has gone wrong clinically.

If you've been losing weight steadily and progress has stalled in the last four to six weeks, that is almost certainly a plateau rather than treatment failure, and our guide to why weight loss can stop on semaglutide even when it was working walks through the most common reasons in detail. It is different from never having lost weight in the first place, which is addressed on the page covering zero weight loss on Wegovy. For people in a genuine plateau, increasing physical activity (particularly resistance exercise, which supports muscle mass and metabolic rate) is often the most evidence-consistent intervention. A dose review may also be appropriate depending on what level you are currently at.

Patience is harder advice than a pill, but it is accurate. Most plateaus resolve within eight to twelve weeks if the treatment approach remains consistent.

Other factors a prescriber should rule out

Some people are genuinely not losing weight with Wegovy because something else is interfering. Hypothyroidism is the most common clinical reason, an underactive thyroid significantly reduces metabolic rate, and it is easily missed if thyroid function has not been checked recently. Polycystic ovary syndrome (PCOS), Cushing's syndrome and certain medicines (notably steroids, antipsychotics and some antidepressants) can all blunt weight-loss responses to semaglutide. If you are looking for a thorough breakdown of the clinical and lifestyle factors that explain why semaglutide may not be producing weight loss, that resource covers each cause and what can be done about it. A GP or prescriber who knows your full medication list and has access to basic blood tests can identify these factors. A clinical review when Wegovy is not working is the right first step rather than stopping treatment.

Storage is also worth confirming once: Wegovy pens must be refrigerated between 2°C and 8°C. A pen left in a warm handbag repeatedly, or stored in the fridge door where temperatures fluctuate, may degrade. The Patient Information Leaflet gives the exact guidance on room-temperature windows and what to do if a pen has been out of the cold, always check it rather than guessing. On the question of how quickly semaglutide produces results, realistic expectations also matter: the trial data reflects a 68-week programme, not a six-week sprint.

If you want a clinical perspective on your specific situation, our prescribers at nume's treatment consultation can review what is happening and whether any changes are warranted.